Brief: Pierrel unit starts clinical trial phase for Ubigel

Pierrel SpA

23/05/2016 12:21

May 23 (Reuters) - Pierrel SpA  PRL.MI : 
    * Aims to reach FY 2016 gross revenue of 15.9 million euros 
($17.82 million) 
    * Aims to reach FY 2016 EBITDA of 0.5 million euros   
    * Board updated its 2016 financial targets on April 20 
 urn:newsml:reuters.com:*:nBIA2140c 
    * Unit Pierrel Pharma has started clinical trials for 
Ubigel, a gel for the treatment of periodontitis 
 
     
  
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nBIA2306b 
     
 Further company coverage:  PRL.MI   
    
 
 
 
 
($1 = 0.8921 euros) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))